HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.

HLB Therapeutics Co.,Ltd.

115450

Classement en actions #18756
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Prix de l'action
$1.87
Capitalisation boursière
$175.95M
Changement (1 jour)
-0.74%
Changement (1 an)
-10.96%
Pays
KR
Échange HLB Therapeutics Co.,Ltd. (115450)

Catégorie

Healthcare
Le prix 115450 avec la capitalisation boursière de B
HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.
115450
$1.87
Capitalisation boursière de HLB Therapeutics Co.,Ltd.(115450)
Capitalisation boursière: $175.95M
En October 2026, HLB Therapeutics Co.,Ltd. a une capitalisation boursière de $175.95M. Cela fait de HLB Therapeutics Co.,Ltd. la 18756th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de HLB Therapeutics Co.,Ltd. du 2010 au 2026
115450 par rapport au top 5 des plus populaires stocks
Prix pour 115450 L’actif B La capitalisation boursière de B Résultats
HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.
$55,350.21 $175.95M
$5.216T +2,964,508.28%
HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.
$52,543.40 $175.95M
$4.952T +2,814,173.33%
HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.
$43,481.18 $175.95M
$4.098T +2,328,792.55%
HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.
$41,821.20 $175.95M
$3.941T +2,239,882.29%
HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.
$30,017.71 $175.95M
$2.829T +1,607,676.40%